Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Environ Toxicol Chem ; 42(8): 1763-1771, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-37204205

RESUMO

New approach methods (NAMs) are increasingly important to help accelerate the pace of ecological risk assessment and offer more ethical, affordable, and efficient alternatives to traditional toxicity tests. In the present study, we describe the development, technical characterization, and initial testing of a toxicogenomics tool, EcoToxChip (384-well quantitative polymerase chain reaction [qPCR] array), to support chemical management and environmental monitoring for three laboratory model species-fathead minnow (Pimephales promelas), African clawed frog (Xenopus laevis), and Japanese quail (Coturnix japonica). Chip design, including gene selection, was informed by a diverse end-user group and quality control metrics (e.g., primer assay, reverse transcription, and PCR efficiency) performed well based on a priori established criteria. Correlation with RNA sequencing (seq) data provided additional confidence in this novel toxicogenomics tool. Although the present study represents an initial testing of only 24 EcoToxChips for each of the model species, the results provide increased confidence in the robustness/reproducibility of EcoToxChips for evaluating perturbations in gene expression associated with chemical exposure and thus, this NAM, combined with early-life stage toxicity testing, could augment current efforts for chemical prioritization and environmental management. Environ Toxicol Chem 2023;42:1763-1771. © 2023 SETAC.


Assuntos
Cyprinidae , Poluentes Químicos da Água , Animais , Coturnix/genética , Toxicogenética , Reprodutibilidade dos Testes , Conservação dos Recursos Naturais , Cyprinidae/metabolismo , Medição de Risco , Poluentes Químicos da Água/toxicidade
2.
Integr Environ Assess Manag ; 16(2): 269-281, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31944596

RESUMO

Given current legislative mandates to assess the safety of thousands of chemicals and the slow pace at which conventional testing proceeds, there is a need to accelerate chemical risk assessment. Governments and businesses are increasingly interested in new approach methodologies (NAMs) that promise to reduce costs and delays. We explore 5 sociological factors within the ecotoxicology community that can influence the perception of NAMs: 1) professional profile (educational cohort, employer), 2) internal science communication within professional forums, 3) concern for "error cost," 4) collaboration across stakeholders, and 5) fundamental beliefs regarding toxicology. We conducted an online survey (n = 171; 2018) asking participants about their experiences and perspectives at events of the Society of Environmental Toxicology and Chemistry (SETAC) to assess 1) how NAMs are discussed compared to conventional testing and 2) how respondents perceive their viability. We developed ordered logistic regression (OLR) models to understand the influence of exploratory variables (cohort, core views on toxicology, frequency of collaboration) on respondents' evaluation of the viability of different NAMs. Our results showed that 1) NAMs were more likely than conventional methods to be challenged in forum discussions, which may be fueled by concerns for error costs in regulatory decision making; 2) perceptions of the viability of NAMs tended to follow a "pattern of familiarity," whereby respondents that were more knowledgeable about a test method tended to find it more viable; 3) respondents who agreed with the Paracelsus maxim had a greater likelihood of finding conventional testing viable; and 4) the more a respondent reported collaborating with industry on alternative testing strategies, the more likely she or he was to report that NAMs were less viable. These results suggest that there are professional and organizational barriers to greater acceptance of NAMs that can be addressed through a social learning process within the professional community. Integr Environ Assess Manag 2020;16:269-281. © 2020 SETAC.


Assuntos
Tomada de Decisões , Ecotoxicologia , Medição de Risco , Comunicação
5.
Health Care Manage Rev ; 27(3): 74-88, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12146786

RESUMO

This article, based on a longitudinal case study, investigates the development, testing, and adoption of innovations in the treatment of HIV/AIDS. Findings indicate that distinguishing between "evidence production" and "adoption" can be difficult because the adoption of innovations is a negotiated outcome and the nature and role of evidence are not given, stable and exogenous to the adoption process. This means that changes to the distribution of discursive legitimacy and credibility in an adopting system can change evidence production and evaluation, and hence patterns of adoption of innovations.


Assuntos
Fármacos Anti-HIV , Tomada de Decisões , Difusão de Inovações , Aprovação de Drogas/organização & administração , Medicina Baseada em Evidências , Infecções por HIV/tratamento farmacológico , Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Síndrome da Imunodeficiência Adquirida/epidemiologia , Fármacos Anti-HIV/classificação , Fármacos Anti-HIV/uso terapêutico , Centers for Disease Control and Prevention, U.S. , Defesa do Consumidor , Infecções por HIV/epidemiologia , Humanos , Estudos Longitudinais , Negociação , Inovação Organizacional , Estados Unidos , United States Food and Drug Administration
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA